39 related articles for article (PubMed ID: 24002436)
1. Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target.
Ma XL; Sun YF; Wang BL; Shen MN; Zhou Y; Chen JW; Hu B; Gong ZJ; Zhang X; Cao Y; Pan BS; Zhou J; Fan J; Guo W; Yang XR
BMC Cancer; 2019 Aug; 19(1):760. PubMed ID: 31370822
[TBL] [Abstract][Full Text] [Related]
2. Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma.
Nishii T; Yashiro M; Shinto O; Sawada T; Ohira M; Hirakawa K
Cancer Sci; 2009 Aug; 100(8):1397-402. PubMed ID: 19493275
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different hepatocyte cell lines for use in a hybrid artificial liver model.
Takagi M; Fukuda N; Yoshida T
Cytotechnology; 1997 May; 24(1):39-45. PubMed ID: 22358595
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression.
Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL
Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375
[TBL] [Abstract][Full Text] [Related]
5. Turning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.
Chan LH; Luk ST; Ma S
Mol Cells; 2015 Mar; 38(3):202-9. PubMed ID: 25666349
[TBL] [Abstract][Full Text] [Related]
6. The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues.
Wang L; Yu J; Xu J; Zheng C; Li X; Du J
Gene; 2015 Jan; 554(1):1-8. PubMed ID: 25452192
[TBL] [Abstract][Full Text] [Related]
7. EpCAM-targeted therapy for human hepatocellular carcinoma.
Ogawa K; Tanaka S; Matsumura S; Murakata A; Ban D; Ochiai T; Irie T; Kudo A; Nakamura N; Tanabe M; Arii S
Ann Surg Oncol; 2014 Apr; 21(4):1314-22. PubMed ID: 24370904
[TBL] [Abstract][Full Text] [Related]
8. Side population cell fractions from hepatocellular carcinoma cell lines increased with tumor dedifferentiation, but lack characteristic features of cancer stem cells.
Nakayama M; Ogasawara S; Akiba J; Ueda K; Koura K; Todoroki K; Kinoshita H; Yano H
J Gastroenterol Hepatol; 2014 May; 29(5):1092-101. PubMed ID: 24325739
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of DDIT4 and TPTEP1 are associated with metastasis and advanced stages in colorectal cancer patients: a study utilizing bioinformatics prediction and experimental validation.
Fattahi F; Kiani J; Alemrajabi M; Soroush A; Naseri M; Najafi M; Madjd Z
Cancer Cell Int; 2021 Jun; 21(1):303. PubMed ID: 34107956
[TBL] [Abstract][Full Text] [Related]
10. Co-regulatory Network of Oncosuppressor miRNAs and Transcription Factors for Pathology of Human Hepatic Cancer Stem Cells (HCSC).
Mohamed RH; Abu-Shahba N; Mahmoud M; Abdelfattah AMH; Zakaria W; ElHefnawi M
Sci Rep; 2019 Apr; 9(1):5564. PubMed ID: 30944375
[TBL] [Abstract][Full Text] [Related]
11. Comparative proteomics of side population cells derived from human hepatocellular carcinoma cell lines with varying metastatic potentials.
Liu H; Wang Y; Xing X; Sun Y; Wei D; Chen G; Liu Q; Chen S; Liu X; Liu J
Oncol Lett; 2018 Jul; 16(1):335-345. PubMed ID: 29928419
[TBL] [Abstract][Full Text] [Related]
12. miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1.
Liu Q; Xu Y; Wei S; Gao W; Chen L; Zhou T; Wang Z; Ying M; Zheng Q
Biosci Rep; 2015 May; 35(4):. PubMed ID: 25997710
[TBL] [Abstract][Full Text] [Related]
13. The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review.
Valencia-Quintana R; Sánchez-Alarcón J; Tenorio-Arvide MG; Deng Y; Montiel-González JM; Gómez-Arroyo S; Villalobos-Pietrini R; Cortés-Eslava J; Flores-Márquez AR; Arenas-Huertero F
Front Microbiol; 2014; 5():102. PubMed ID: 24672518
[TBL] [Abstract][Full Text] [Related]
14. Identification of cancer stem cells from hepatocellular carcinoma cell lines and their related microRNAs.
Xu Y; Xie Y; Wang X; Chen X; Liu Q; Ying M; Zheng Q
Oncol Rep; 2013 Nov; 30(5):2056-62. PubMed ID: 24002436
[TBL] [Abstract][Full Text] [Related]
15. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties.
Chiba T; Kita K; Zheng YW; Yokosuka O; Saisho H; Iwama A; Nakauchi H; Taniguchi H
Hepatology; 2006 Jul; 44(1):240-51. PubMed ID: 16799977
[TBL] [Abstract][Full Text] [Related]
16. Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines.
Zhuo L; Liu J; Wang B; Gao M; Huang A
Oncol Rep; 2013 Feb; 29(2):555-62. PubMed ID: 23229111
[TBL] [Abstract][Full Text] [Related]
17. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb.
Zhang J; Luo N; Luo Y; Peng Z; Zhang T; Li S
Int J Oncol; 2012 Mar; 40(3):747-56. PubMed ID: 22025269
[TBL] [Abstract][Full Text] [Related]
18. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells.
Mamoori A; Gopalan V; Smith RA; Lam AK
Biol Cell; 2016 Mar; 108(3):51-64. PubMed ID: 26712035
[TBL] [Abstract][Full Text] [Related]
19. Emerging role of microRNAs in cancer and cancer stem cells.
Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J
J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
